Your browser doesn't support javascript.
loading
First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors.
Bauer, Todd; Cho, Byong Chul; Heist, Rebecca; Bazhenova, Lyudmila; Werner, Theresa; Goel, Sanjay; Kim, Dong-Wan; Adkins, Douglas; Carvajal, Richard D; Alva, Ajjai; Eaton, Keith; Wang, Judy; Liu, Yong; Yan, Xiaohong; Christensen, Jamie; Neuteboom, Saskia; Chao, Richard; Pant, Shubham.
Afiliación
  • Bauer T; Department of Drug Development, Sarah Cannon Research Institute, Tennessee Oncology, 250 25th Ave North, Ste 100, Nashville, TN, 37203, USA. tbauer@tnonc.com.
  • Cho BC; Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Heist R; Massachusetts General Hospital, Boston, MA, USA.
  • Bazhenova L; University of California San Diego, Moores Cancer Center, La Jolla, CA, USA.
  • Werner T; Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, USA.
  • Goel S; Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY, USA.
  • Kim DW; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
  • Adkins D; Washington University, St. Louis, MO, USA.
  • Carvajal RD; Columbia University Irving Medical Center, New York, NY, USA.
  • Alva A; University of Michigan Medical Center, Ann Arbor, MI, USA.
  • Eaton K; University of Washington, Seattle, WA, USA.
  • Wang J; Sarah Cannon Research Institute, Florida Cancer Specialists, Sarasota, FL, USA.
  • Liu Y; Mirati Therapeutics, Inc, San Diego, CA, USA.
  • Yan X; Mirati Therapeutics, Inc, San Diego, CA, USA.
  • Christensen J; Mirati Therapeutics, Inc, San Diego, CA, USA.
  • Neuteboom S; Mirati Therapeutics, Inc, San Diego, CA, USA.
  • Chao R; Mirati Therapeutics, Inc, San Diego, CA, USA.
  • Pant S; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Invest New Drugs ; 40(5): 990-1000, 2022 10.
Article en En | MEDLINE | ID: mdl-35767205

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridinas / Anilidas / Neoplasias Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piridinas / Anilidas / Neoplasias Límite: Humans Idioma: En Revista: Invest New Drugs Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos